Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...

Dole plc (NYSE:DOLE) Q4 2025 Earnings Call Transcript February 25, 2026 Dole plc beats earnings expectations. Reported EPS is ...

Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, ...

New AI capabilities drive smarter automation, enriched metadata, and assisted workflow design for live and file-based ...

The second forum of the University of Alberta Students’ Union (SU) 2026 elections was held at Campus Saint-Jean (CSJ) on ...